lobbying_activities: 2379573

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2379573	9b0a2f75-6f8e-4aa4-aaf8-43369c70a569	Q4	HOLLAND & KNIGHT LLP	18466	ALLIANCE FOR REGENERATIVE MEDICINE	2019	fourth_quarter	MMM	Patient Affordability, Value and Efficiency Act; S.2543, Prescription Drug Pricing Reduction Act of 2019; regulatory reimbursement issues; "Value Based Payment" draft legislation; H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act.	Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2020-01-11T18:33:02.977000-05:00